**Core Concept**
Diabetic nephropathy is a leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. It is characterized by the accumulation of extracellular matrix proteins in the renal glomeruli, leading to glomerular hypertrophy and sclerosis.

**Why the Correct Answer is Right**
Diabetic nephropathy is caused by the activation of various signaling pathways in the renal glomeruli, including the renin-angiotensin-aldosterone system (RAAS) and the transforming growth factor-beta (TGF-β) pathway. The activation of these pathways leads to the increased expression of genes involved in extracellular matrix production, such as collagen and fibronectin. The accumulation of these proteins in the glomeruli leads to glomerular hypertrophy and sclerosis, which are hallmark features of diabetic nephropathy.

**Why Each Wrong Option is Incorrect**
**Option A:** Diabetic nephropathy is characterized by the loss of renal function, which is a result of the accumulation of extracellular matrix proteins in the renal glomeruli. Therefore, this statement is true.

**Option B:** The RAAS and TGF-β pathways are activated in diabetic nephropathy, leading to the increased expression of genes involved in extracellular matrix production. Therefore, this statement is true.

**Option C:** Diabetic nephropathy is associated with the activation of various inflammatory pathways, including the NF-κB pathway. Therefore, this statement is true.

**Option D:** Diabetic nephropathy is characterized by the loss of renal function, which is a result of the accumulation of extracellular matrix proteins in the renal glomeruli. However, diabetic nephropathy is not typically associated with the formation of amyloid deposits, which are characteristic of other types of kidney disease, such as amyloidosis.

**Clinical Pearl / High-Yield Fact**
The early detection and treatment of diabetic nephropathy can prevent the progression of kidney disease and reduce the risk of cardiovascular complications. Regular monitoring of renal function and the use of renin-angiotensin-aldosterone system (RAAS) inhibitors can help to slow the progression of kidney disease.

**Correct Answer: D.**